BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474
104 results:

  • 1. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
    Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
    Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Apoptosis antagonizing transcription factor-mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis-hepatocellular carcinoma.
    Srinivas AN; Suresh D; Chidambaram SB; Santhekadur PK; Kumar DP
    J Cell Physiol; 2024 Jan; 239(1):135-151. PubMed ID: 37942831
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hepatitis B Virus x Protein Increases Cellular OCT3/4 and MYC and Facilitates Cellular Reprogramming.
    Sanal MG; Gupta S; Saha R; Vats N; Sarin SK
    Cell Reprogram; 2023 Oct; 25(5):224-237. PubMed ID: 37769039
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CircHULC accelerates the growth of human liver cancer stem cells by enhancing chromatin reprogramming and chromosomal instability via autophagy.
    Song S; Wang L; Jiang X; Liu X; Li S; Xie S; Lu D
    Cell Signal; 2023 Sep; 109():110772. PubMed ID: 37321526
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ABI2-mediated MEOX2/klf4-NANOG axis promotes liver cancer stem cell and drives tumour recurrence.
    Chen J; Li H; Zhang B; Xiong Z; Jin Z; Chen J; Zheng Y; Zhu X; Zhang S
    Liver Int; 2022 Nov; 42(11):2562-2576. PubMed ID: 36017822
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oncofetal proteins and cancer stem cells.
    Yan Q; Fang X; Li C; Lan P; Guan X
    Essays Biochem; 2022 Sep; 66(4):423-433. PubMed ID: 35670043
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Circ_CDR1as: A circular RNA with roles in the carcinogenesis.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Sarfaraz S; Taheri M; Ayatollahi SA
    Pathol Res Pract; 2022 Aug; 236():153968. PubMed ID: 35667198
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. klf4 Alleviates Hypertrophic Scar Fibrosis by Directly Activating BMP4 Transcription.
    Wang J; Zhao M; Zhang H; Yang F; Luo L; Shen K; Wang X; Li Y; Zhang J; Zhang J; Wang K; Li J; Wang Y; Yang Y; Hu D
    Int J Biol Sci; 2022; 18(8):3324-3336. PubMed ID: 35637963
    [No Abstract]    [Full Text] [Related]  

  • 9. Epigenetic regulation of the DNMT1/MT1G/klf4/CA9 axis synergises the anticancer effects of sorafenib in hepatocellular carcinoma.
    Wei T; Lin R; Fu X; Lu Y; Zhang W; Li Z; Zhang J; Wang H
    Pharmacol Res; 2022 Jun; 180():106244. PubMed ID: 35550167
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis.
    Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S
    J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
    Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
    Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. USP11 degrades klf4 via its deubiquitinase activity in liver diseases.
    Yang H; Park D; Ryu J; Park T
    J Cell Mol Med; 2021 Jul; 25(14):6976-6987. PubMed ID: 34114341
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
    Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
    Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer.
    Fatma H; Siddique HR
    Expert Rev Anticancer Ther; 2021 Aug; 21(8):853-864. PubMed ID: 33832395
    [No Abstract]    [Full Text] [Related]  

  • 15. AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.
    Bian X; Shi D; Xing K; Zhou H; Lu L; Yu D; Wu W
    Clin Transl Med; 2021 Mar; 11(3):e352. PubMed ID: 33783988
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
    Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
    Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
    Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
    Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
    Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
    J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The association between klf4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection.
    Xue M; Zhou C; Zheng Y; Zhang Z; Wang S; Fu Y; Atyah M; Xue X; Zhu L; Dong Q; Jia H; Ren N; Hu R
    Aging (Albany NY); 2020 Aug; 12(15):15566-15580. PubMed ID: 32756012
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
    Moulik S; Karmakar J; Joshi S; Dube A; Mandal C; Chatterjee M
    Parasite Immunol; 2021 Jan; 43(1):e12783. PubMed ID: 32734677
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.